BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18362904)

  • 1. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.
    Sacchi N; Costeas P; Hartwell L; Hurley CK; Raffoux C; Rosenmayr A; Greinix H;
    Bone Marrow Transplant; 2008 Jul; 42(1):9-14. PubMed ID: 18362904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).
    Wiegand T; Raffoux C; Hurley CK; Kern M; Oudshoorn M; Raymond J; Cleaver S; Marry E; Muller C; ;
    Bone Marrow Transplant; 2004 Jul; 34(2):97-101. PubMed ID: 15170174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
    Hurley CK; Wade JA; Oudshoorn M; Middleton D; Kukuruga D; Navarrete C; Christiansen F; Hegland J; Ren EC; Andersen I; Cleaver SA; Brautbar C; Raffoux C
    Bone Marrow Transplant; 1999 Jul; 24(2):119-21. PubMed ID: 10456664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.
    Hurley CK; Raffoux C;
    Bone Marrow Transplant; 2004 Jul; 34(2):103-10. PubMed ID: 15170173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
    Shaw BE; Ball L; Beksac M; Bengtsson M; Confer D; Diler S; Fechter M; Greinix H; Koh M; Lee S; Nicoloso-De-Faveri G; Philippe J; Pollichieni S; Pulsipher M; Schmidt A; Yang E; van Walraven AM; ;
    Bone Marrow Transplant; 2010 May; 45(5):832-8. PubMed ID: 20173787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
    Bray RA; Hurley CK; Kamani NR; Woolfrey A; Müller C; Spellman S; Setterholm M; Confer DL
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):45-53. PubMed ID: 18721780
    [No Abstract]   [Full Text] [Related]  

  • 7. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
    Hurley CK; Foeken L; Horowitz M; Lindberg B; McGregor M; Sacchi N;
    Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exclusion of deceased donors post-procurement of tissues.
    Chandrasekar A; Warwick RM; Clarkson A
    Cell Tissue Bank; 2011 Aug; 12(3):191-8. PubMed ID: 20505995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical examination of the potential tissue donor, what does literature tell us?
    Beele H; Van Wijk M; Bokhorst A; Van Geyt C
    Cell Tissue Bank; 2009 Aug; 10(3):253-7. PubMed ID: 19048394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA).
    Cleaver SA; Warren P; Kern M; Hurley CK; Raffoux C; Keller J; Kiesel U; Koza V; Marry E; Mitterschiffthaler A; Nakamura M; Okah CT; Persson U; Radde-Stepaniak T; Ranson L; Raymond J; do Rosario Sancho M; Varla-Leftherioti M; Wiegand T; Winterhager JM; Woodfield DG
    Bone Marrow Transplant; 1997 Oct; 20(8):621-9. PubMed ID: 9383224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL; Coppo PA; Confer DL
    Clin Transpl; 1999; ():121-7. PubMed ID: 11038630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded criteria living donors: how far can we go?
    Serur D; Charlton M
    Prog Transplant; 2012 Jun; 22(2):129-32; quiz 133. PubMed ID: 22878068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.
    Foeken LM; Green A; Hurley CK; Marry E; Wiegand T; Oudshoorn M;
    Bone Marrow Transplant; 2010 May; 45(5):811-8. PubMed ID: 20154736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for new donor typing based on donor HLA type or donor characteristics.
    Little AM; Jindra P; Raffoux C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.
    Rosenmayr A; Hartwell L; Egeland T;
    Bone Marrow Transplant; 2003 Apr; 31(7):539-45. PubMed ID: 12692618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a need to mandate kidney transplant living donor registries.
    Emara M; Ragheb A; Hassan A; Shoker A
    Clin Transplant; 2008; 22(5):525-31. PubMed ID: 18549448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell donor selection: the Europdonor experience.
    Oudshoorn M; van Walraven SM; Bakker JN; Lie JL; V D Zanden HG; Heemskerk MB; Claas FH
    Hum Immunol; 2006 Jun; 67(6):405-12. PubMed ID: 16728261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks.
    Bochtler W; Maiers M; Oudshoorn M; Marsh SG; Raffoux C; Mueller C; Hurley CK
    Bone Marrow Transplant; 2007 Jun; 39(12):737-41. PubMed ID: 17438587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
    Confer DL; Abress LK; Navarro W; Madrigal A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S8-S11. PubMed ID: 19892026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.